We are live on ! Find out more
EC

EntryPoint Capital Portfolio holdings

AUM $341M
1-Year Est. Return 20.57%
This Fund
S&P 500
This Quarter Est. Return
+2.29%
1 Year Est. Return
+20.57%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$112M
AUM Growth
+$7.22M
Cap. Flow
+$6.17M
Cap. Flow %
5.54%
Top 10 Hldgs %
3.56%
Holding
1,843
New
512
Increased
412
Reduced
454
Closed
458

Top Buys

Rank Stock Value
1
UIS icon
Unisys
UIS
+$562K
2
FLGT icon
Fulgent Genetics
FLGT
+$385K
3
SDGR icon
Schrodinger
SDGR
+$384K
4
AGYS icon
Agilysys
AGYS
+$367K
5
RIOT icon
Riot Platforms
RIOT
+$344K

Top Sells

Rank Stock Value
1
NEXT icon
NextDecade
NEXT
+$565K
2
AMWL icon
American Well
AMWL
+$535K
3
IHRT icon
iHeartMedia
IHRT
+$499K
4
RILY icon
BRC Group Holdings
RILY
+$497K
5
LXRX icon
Lexicon Pharmaceuticals
LXRX
+$496K

Sector Composition

Rank Sector Weight
1 Healthcare 20.49%
2 Industrials 17.12%
3 Technology 16.79%
4 Financials 12.57%
5 Consumer Discretionary 12.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPSC icon
201
SPS Commerce
SPSC
$2.25B
$157K 0.14%
+848
New +$157K
PJT icon
202
PJT Partners
PJT
$4.37B
$157K 0.14%
1,662
+359
+28% +$35.3K
PRIM icon
203
Primoris Services
PRIM
$4.69B
$157K 0.14%
3,677
+513
+16% +$18.9K
NMIH icon
204
NMI Holdings
NMIH
$3.25B
$156K 0.14%
4,816
-749
-13% -$22.6K
FOLD
205
DELISTED
Amicus Therapeutics
FOLD
$156K 0.14%
13,218
+9,729
+279% +$124K
UVV icon
206
Universal Corp
UVV
$1.34B
$156K 0.14%
+3,008
New +$164K
DCPH
207
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$154K 0.14%
9,795
-775
-7% -$11.9K
WBD icon
208
Warner Bros
WBD
$64.6B
$154K 0.14%
17,611
+6,442
+58% +$62.1K
DLX icon
209
Deluxe
DLX
$1.19B
$153K 0.14%
+7,450
New +$148K
GILD icon
210
Gilead Sciences
GILD
$161B
$153K 0.14%
2,094
-355
-14% -$27.3K
GRPN icon
211
Groupon
GRPN
$980M
$153K 0.14%
+11,498
New +$175K
IGMS
212
DELISTED
IGM Biosciences
IGMS
$152K 0.14%
+15,801
New +$183K
NPK icon
213
National Presto Industries
NPK
$891M
$152K 0.14%
+1,819
New +$144K
CSGS
214
DELISTED
CSG Systems International
CSGS
$152K 0.14%
2,953
+158
+6% +$8.21K
PGNY icon
215
Progyny
PGNY
$2.44B
$152K 0.14%
3,989
+1,892
+90% +$71.5K
ITCI
216
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$150K 0.13%
2,167
+1,259
+139% +$86.5K
VRT icon
217
Vertiv
VRT
$112B
$150K 0.13%
1,832
-3,360
-65% -$211K
CVGW
218
DELISTED
Calavo Growers
CVGW
$150K 0.13%
5,380
+4,094
+318% +$115K
IRMD icon
219
iRadimed
IRMD
$1.21B
$150K 0.13%
+3,399
New +$150K
CNDT icon
220
Conduent
CNDT
$230M
$149K 0.13%
44,162
-40,046
-48% -$139K
MTRX icon
221
Matrix Service
MTRX
$347M
$149K 0.13%
11,434
-11,889
-51% -$133K
DCI icon
222
Donaldson
DCI
$10.8B
$148K 0.13%
1,986
+938
+90% +$63.8K
MMM icon
223
3M
MMM
$89B
$148K 0.13%
1,995
+1,500
+303% +$124K
MOV icon
224
Movado Group
MOV
$812M
$148K 0.13%
5,293
+1,859
+54% +$52.1K
LRCX icon
225
Lam Research
LRCX
$382B
$148K 0.13%
1,520
+1,190
+361% +$105K
7 8
9
10 11

Similar funds

SFA
Seneca Financial Advisors Rochester, New York $341M AUM 14.73% 1-Year Est. Return
FCM
Findell Capital Management New York $341M AUM 135.6% 1-Year Est. Return
CPI
Crestview Partners II New York $341M AUM 17.29% 1-Year Est. Return
SW
SMART Wealth Omaha, Nebraska $341M AUM 24.37% 1-Year Est. Return
MTIC
Missouri Trust & Investment Company Springfield, Missouri $341M AUM 17.31% 1-Year Est. Return
KFSC
Keystone Financial Services (Colorado) Loveland, Colorado $341M AUM 18.11% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return
SC
Slotnik Capital Dallas, Texas $342M AUM 105.92% 1-Year Est. Return

EntryPoint Capital's Q1 2024 Portfolio in Review

As of Q1 2024, EntryPoint Capital held 1,843 positions worth $112M, up 6.9% from $104M the previous quarter. Its ten largest holdings account for 3.6% of the portfolio.

EntryPoint Capital deployed $6.17M of net new capital in Q1 2024, opening 512 new positions and adding to 412 existing holdings. Its largest new stake was Unisys: 92,556 shares worth $454K.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 19% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was NextDecade, an estimated $565K trimmed.

  • EntryPoint Capital's largest Q1 2024 buy was Unisys: 92,556 shares worth $454K.
  • EntryPoint Capital added most to Fulgent Genetics in Q1 2024, an estimated $385K increase.
  • EntryPoint Capital's biggest Q1 2024 reduction was NextDecade, cutting an estimated $565K.
  • EntryPoint Capital fully exited American Well in Q1 2024, selling an estimated $535K.
  • EntryPoint Capital's ten largest holdings make up 3.6% of its $112M portfolio in Q1 2024.
  • EntryPoint Capital opened 512 new positions and closed 458 in Q1 2024.
  • EntryPoint Capital's portfolio value rose 6.9% quarter-over-quarter to $112M.

Based on EntryPoint Capital's 13F filing for Q1 2024, filed 14 May 2024.